{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:02:26Z","timestamp":1793037746679,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008883","name":"Nagoya Shiritsu Daigaku","doi-asserted-by":"publisher","award":["2213003"],"award-info":[{"award-number":["2213003"]}],"id":[{"id":"10.13039\/501100008883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ctro.2023.100648","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T12:53:28Z","timestamp":1685710408000},"page":"100648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-4637","authenticated-orcid":false,"given":"Nozomi","family":"Kita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-0119","authenticated-orcid":false,"given":"Natsuo","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2667-8923","authenticated-orcid":false,"given":"Taiki","family":"Takaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0936-2633","authenticated-orcid":false,"given":"Dai","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-5811","authenticated-orcid":false,"given":"Masanari","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-2974","authenticated-orcid":false,"given":"Akira","family":"Torii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6990-9923","authenticated-orcid":false,"given":"Seiya","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Mekata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Hiwatashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctro.2023.100648_b0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ctro.2023.100648_b0010","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2023.100648_b0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/ajco.13731","article-title":"Role of stereotactic body radiotherapy for early-stage non-small-cell lung cancer in patients borderline for surgery due to impaired pulmonary function","volume":"18","author":"Tomita","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100648_b0020","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ijrobp.2020.10.011","article-title":"Safety, efficacy, and patterns of failure after single-fraction stereotactic body radiation therapy (SBRT) for oligometastases","volume":"109","author":"Sogono","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2023.100648_b0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijrobp.2010.08.056","article-title":"A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy","volume":"82","author":"Barriger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2023.100648_b0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.03.041","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung","volume":"85","author":"Baker","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2023.100648_b0035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2013.08.020","article-title":"The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer","volume":"87","author":"Allibhai","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2023.100648_b0040","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ijrobp.2014.01.022","article-title":"Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a \u201cno fly zone\u201d","volume":"88","author":"Chang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2023.100648_b0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.21037\/jtd.2017.12.22","article-title":"Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy","volume":"10","author":"Takeda","year":"2018","journal-title":"J Thorac Dis"},{"issue":"4","key":"10.1016\/j.ctro.2023.100648_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/02841860802520821","article-title":"Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy","volume":"48","author":"Ricardi","year":"2009","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100648_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-2-21","article-title":"Exceptionally high incidence of symptomatic grade 2\u20135 radiation pneumonitis after stereotactic radiation therapy for lung tumors","volume":"2","author":"Yamashita","year":"2007","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100648_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-5-81","article-title":"Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size","volume":"5","author":"Baba","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2023.100648_b0065","doi-asserted-by":"crossref","unstructured":"Kita N, Tomita N, Takaoka T, Sudo S, Tsuzuki Y, Okazaki D, et al. Comparison of recurrence patterns between adenocarcinoma and squamous cell carcinoma after stereotactic body radiotherapy for early-stage lung cancer. Cancers (Basel) 2023;15. doi: 10.3390\/CANCERS15030887.","DOI":"10.3390\/cancers15030887"},{"key":"10.1016\/j.ctro.2023.100648_b0070","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12094-020-02459-8","article-title":"Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules","volume":"23","author":"Tomita","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctro.2023.100648_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1269\/jrr.11095","article-title":"Radiobiological evaluation of the radiation dose as used inhigh-precision radiotherapy: Effect of prolonged deliverytime and applicability of the linear-quadratic model","volume":"53","author":"Shibamoto","year":"2012","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ctro.2023.100648_b0080","first-page":"11","article-title":"A critical review of recent developments in radiotherapy for non-small cell lung cancer","author":"Baker","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2023.100648_b0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"30","key":"10.1016\/j.ctro.2023.100648_b0090","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100648_b0095","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2008.11.042","article-title":"Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study","volume":"75","author":"Fakiris","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2023.100648_b0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2008.12.016","article-title":"Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus","volume":"66","author":"Song","year":"2009","journal-title":"Lung Cancer"},{"issue":"15","key":"10.1016\/j.ctro.2023.100648_b0105","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2023.100648_b0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2020.10.015","article-title":"Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer","volume":"156","author":"Liu","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1073","key":"10.1016\/j.ctro.2023.100648_b0115","doi-asserted-by":"crossref","first-page":"20160508","DOI":"10.1259\/bjr.20160508","article-title":"Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours","volume":"90","author":"Okubo","year":"2017","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100648_b0120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/JTO.0000000000000359","article-title":"Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer","volume":"10","author":"Ueki","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2023.100648_b0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/cancers10080257","article-title":"Stereotactic body radiation therapy for patients with pulmonary interstitial change: High incidence of fatal radiation pneumonitis in a retrospective multi-institutional study","volume":"10","author":"Onishi","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2023.100648_b0130","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/j.prro.2018.09.003","article-title":"Impact of tumor size on local control and pneumonitis after stereotactic body radiation therapy for lung tumors","volume":"9","author":"Parker","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2023.100648_b0135","doi-asserted-by":"crossref","unstructured":"Matsuo Y, Shibuya K, Nakamura M, Narabayashi M, Sakanaka K, Ueki N, et al. Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2012;83. doi: 10.1016\/J.IJROBP.2012.01.018.","DOI":"10.1016\/j.ijrobp.2012.01.018"},{"issue":"5","key":"10.1016\/j.ctro.2023.100648_b0140","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ijrobp.2016.03.024","article-title":"Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: A pooled analysis of 88 studies","volume":"95","author":"Zhao","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2023.100648_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00408-007-9063-5","article-title":"Clinical outcome of stage III non-small-cell lung cancer patients after definitive radiotherapy","volume":"186","author":"Nakamura","year":"2008","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.ctro.2023.100648_b0150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijrobp.2018.11.028","article-title":"Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma?","volume":"110","author":"Kong","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:11:15Z","timestamp":1762503075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":30,"alternative-id":["S2405630823000733"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100648","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100648"}}